Ignite Creation Date:
2024-05-06 @ 7:43 AM
Last Modification Date:
2024-10-26 @ 11:51 AM
Study NCT ID:
NCT02584933
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-17
First Post:
2015-10-06
Brief Title:
Roll-over Study to Allow Access to Certinib LDK378 for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis